A recent report published by Infinium Global Research on the vaccine transport market provides an in-depth analysis of segments and sub-segments in the global as well as regional vaccine transport market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional vaccine transport market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global vaccine transport market. According to the report, the global vaccine transport market is projected to be worth USD 1.8 billion in 2020 and is expected to reach USD 2.8 by 2026, growing with grow at a CAGR of 7.5% over the forecast period of 2020-2026.

Market Insight

The vaccine transport industry has gained impetus due to the outbreak of COVID-19. Improper transportation and supply chain can put vaccine products at risk of degradation. The WHO organization and PATH is to evaluate a range of transportation and storage containers for heat-sensitive drugs and vaccines. The International Air Transport Association robustly recommends governments plan with industry stakeholders for the full preparedness for when COVID-19 vaccines are approved and will be available for distribution.

Growing government support for research activities and clinical trials are provides a growing demand for the market. The introduction of a number of newer and more expensive vaccines has placed significant pressure on vaccine supply chain systems this further provides a growing demand for the vaccine Transport market. The aviation industry is planned to work efficiently to deliver COVID vaccines to the market, once approved. The industry is striving to establish practices including the third-party supply chain and the logistical exercise, to ensure vaccines to the markets.

Additionally, growing government initiatives for vaccine transport are driving the growth of the market. The governments are exploring alternatives to the in-house supply chain model, where governments take full responsibility for their vaccine supply chains and logistics. Countries are developing a new vaccine management system, outsourcing the entire vaccine distribution process to a private distributor. National governments, donors, and international agencies developed a global vision to ensure an efficient management system for vaccine transport. However, complex procedure to maintain vaccine quality throughout the transportation is affecting the growth of the market. Nevertheless, technological advancements in supply chain management will create numerous growth opportunities for the growth of the market.

The spread of coronavirus has led to the rise in the number of research activities to develop a vaccine to cure as well as prevent healthy people from infection. Several vaccine manufacturers across the world have increased their research capacity to find an effective vaccine against the coronavirus. Furthermore, COVID-19 has affected millions of people around the world, which is expected to generate huge demand for vaccines. Higher demand for vaccines is set to put pressure on the manufacturers as well as healthcare professionals to supply the vaccine.

In terms of geography, North America has generated the highest revenue for the vaccine transport market. The developed economies, such as the US and Canada, are the major contributor to the growth of the market in North America. The rising investment by the government organizations and logistics firms to widen efficient cold warehouse and transportation facilities is majorly driving the growth in the North America region. Besides, the presence of major players and stringent regulations concerning the vaccine transport solution is estimated to foster the market. Furthermore, the Asia Pacific region is anticipated to grow at the fastest rate owing to higher demand for pharmaceuticals.

Segment Covered

The report on global vaccine transport market covers segments such as type, and end user. On the basis of type, the sub-markets include sea freight, airfreight, and overland. On the basis of end user, the sub-markets include hospitals, epidemic prevention station, pharmaceutical manufacturers & distributors, clinical research organizations, and others.

Companies Profiled:

The report provides profiles of the companies in the market such as American Airlines Inc, AmerisourceBergen Corporation, Cavalier Logistics, Allcargo Logistics Inc, DB Schenker, Deutsche Post DHL Group, FedEx Corp, Kuehne + Nagel International AG, United Parcel Service, and Globelink China Logistics Limited.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the vaccine transport market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.